Ma’an Amad

928 total citations
8 papers, 483 citations indexed

About

Ma’an Amad is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, Ma’an Amad has authored 8 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Hepatology. Recurrent topics in Ma’an Amad's work include Hepatitis C virus research (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Ma’an Amad is often cited by papers focused on Hepatitis C virus research (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Ma’an Amad collaborates with scholars based in Canada, Germany and Egypt. Ma’an Amad's co-authors include Mohammed Taimi, Christian Helvig, Heather Ramshaw, Jay A. White, Martin Petkovich, Bożena Korczak, Jan Wiśniewski, Michel Garneau, Samuel S. Chuang and Glenville Jones and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Ma’an Amad

8 papers receiving 476 citations

Peers

Ma’an Amad

MB

PHARM

HEPAT

ID

GENET

Graeme C. M. Smith United Kingdom

Claude Souvignet France

Shabnam Malik India

Recaredo Infante France

Ninder Panesar United States

Mary Petrowski United States

Fei Qiu China

Jason E. Drury United States

Dorothy B. Colagiovanni United States

Mack Sobhany United States

Graeme C. M. Smith United Kingdom

Ma’an Amad

197 ×0.8

MB

152 ×1.5

PHARM

61 ×0.7

HEPAT

20 ×0.2

ID

36 ×0.4

GENET

Citations per year, relative to Ma’an Amad Ma’an Amad (= 1×) peers Graeme C. M. Smith

Countries citing papers authored by Ma’an Amad

Since Specialization

Citations

This map shows the geographic impact of Ma’an Amad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ma’an Amad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ma’an Amad more than expected).

Fields of papers citing papers by Ma’an Amad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ma’an Amad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ma’an Amad. The network helps show where Ma’an Amad may publish in the future.

Co-authorship network of co-authors of Ma’an Amad

This figure shows the co-authorship network connecting the top 25 collaborators of Ma’an Amad. A scholar is included among the top collaborators of Ma’an Amad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ma’an Amad. Ma’an Amad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Fader, Lee D., Serge Landry, Sylvie Goulet, et al.. (2013). Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure–activity relationships (SAR) of the C3-phenyl moiety. Bioorganic & Medicinal Chemistry Letters. 23(11). 3401–3405. 16 indexed citations

2.

Duan, Jianmin, Gordon T. Bolger, Michel Garneau, et al.. (2012). The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in Humans. Antimicrobial Agents and Chemotherapy. 56(10). 5381–5386. 18 indexed citations

3.

Duan, Jianmin, Chan‐Loi Yong, Michel Garneau, et al.. (2011). Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor. Xenobiotica. 42(2). 164–172. 13 indexed citations

4.

White, Peter W., Montse Llinàs‐Brunet, Ma’an Amad, et al.. (2010). 777 PRECLINICAL CHARACTERIZATION OF NON-COVALENT HCV NS3/4A PROTEASE INHIBITOR BI 201335. Journal of Hepatology. 52. S302–S302. 4 indexed citations

5.

White, Peter W., Montse Llinàs‐Brunet, Ma’an Amad, et al.. (2010). Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease. Antimicrobial Agents and Chemotherapy. 54(11). 4611–4618. 77 indexed citations

6.

Gagnon, Alexandre, Ma’an Amad, Pierre Bonneau, et al.. (2007). Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. Bioorganic & Medicinal Chemistry Letters. 17(16). 4437–4441. 47 indexed citations

7.

Chuang, Samuel S., Christian Helvig, Mohammed Taimi, et al.. (2004). CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids. Journal of Biological Chemistry. 279(8). 6305–6314. 134 indexed citations

8.

Taimi, Mohammed, Christian Helvig, Jan Wiśniewski, et al.. (2003). A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid. Journal of Biological Chemistry. 279(1). 77–85. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact